Solvay Animal Health, Inc., et al.; Withdrawal of Approval of NADA's

ローカル自動翻訳 · 情報源の原言語

概要

The Food and Drug Administration (FDA) is withdrawing approval of two new animal drug applications (NADA's). One NADA is held by Solvay Animal Health, Inc., and provides for the use of a sulfaquinoxaline soluble powder. The other NADA is held by Pharmachem Corp. and provides for the use of a dextran injection. The sponsors requested withdrawal of approval of the NADA's because they no longer manufacture or distribute the products.

情報源の原言語: Federal Register — Health and Human Services原文の発表を開く →

Solvay Animal Health, Inc., et al.; Withdrawal of Approval of NADA's

Office of Management and Budget (OMB) に提出された情報収集活動; Food and Drug Administration (FDA) の提出書類の提出; Customer/Partner Customer Service Satisfaction Surveys に関するコメントの要求

CDCのデータ収集計画についての意見募集

Office of the National Coordinator for Health Information Technology; Health Information Technology Advisory Committee; エンタイントにそすにしたプログルにしたプログにプログを定义にしたプログに。